profitfromit1@gmail.com

🏥 Apollo Hospitals FY25 Results: Strong Performance Backed by Expansion Plans

Created by Piyush Patel_ in Company Update Visit: 160 5 Jun 2025

🏥 Apollo Hospitals FY25 Results: Strong Performance Backed by Expansion Plans

📅 Date: May 30, 2025
✍️ Author: Piyush Patel
🔍 CMP: ₹6,875 | Sector: Healthcare Services

📌 Executive Summary

Apollo Hospitals Enterprise Ltd., India’s leading integrated healthcare provider, delivered an impressive performance in FY25 with strong earnings growth, margin expansion, and accelerated capacity expansion across metros. With over ₹7,600 crore earmarked for hospital projects and a strategic push in digital health, Apollo continues to reinforce its leadership.

🏨 Hospital Network & Expansion Strategy

Total Census Beds (as of March 2025):

Owned: 8,025
O&M: 790
AHLL (Day Surgery & Birthing): 643
Total: 9,458 beds

Occupancy Rate (FY25):

68% overall | 71% in Metros

Planned Expansion (Next 3–4 Years):

🏗️ 4,372 New Beds (3,577 census beds)
🏙️ Key Cities: Sarjapur, Chennai, Varanasi, Worli, Lucknow
💰 ₹7,603 Cr investment (₹5,521 Cr pending)

📊 Segmental Performance (Q4 FY25 & FY25)

Segment	Revenue Q4FY25 (₹ Cr)	YoY Growth	Revenue FY25 (₹ Cr)	YoY Growth
Healthcare Services	2,821.9	10%	11,147.5	13%
Apollo HealthCo (Pharmacy + Digital)	2,376.3	17%	9,093.0	16%
Apollo Health & Lifestyle Ltd	394.0	11%	1,553.5	14%
Total Consolidated Revenue	5,592.2	13%	21,794.0	14%

📈 Consolidated Income Statement Summary

Metric	Q4 FY25	YoY Growth	FY25	YoY Growth
Revenue (₹ Cr)	5,592.2	13%	21,794.0	14%
EBITDA (₹ Cr)	769.8	20%	3,021.9	13.9%
EBITDA Margin (%)	13.8%	+80 bps	13.9%	+60 bps
PAT (₹ Cr)	389.6	54%	1,445.9	61%
EPS (₹)	27.9	–	90.15	–

📊 Valuation & Key Ratios (at CMP ₹6,875)

Ratio/Metric	Value
PE Ratio	76.3x
Interest Coverage Ratio	8.9x
Price to Book Value	8.6x
Current Ratio	2.4x
Debt-to-Equity Ratio	0.20
Trade Receivables (₹ Cr)	814.8

📘 Consolidated Balance Sheet Snapshot (₹ Cr)

Particulars	FY25	FY24
Total Assets	13,372.3	12,405.2
Total Equity	8,734.2	7,710.9
Total Liabilities	4,638.1	4,694.3
Debt (Long + Short)	17,832.0	19,560.0

💰 Cash Flow Statement Summary (₹ Cr)

Metric	FY25
Operating Cash Flow (CFO)	1,741.9
Investing Cash Flow (CFI)	-1,045.7
Financing Cash Flow (CFF)	-739.1
Net Cash Flow	-42.9
Estimated Free Cash Flow (FCF)	883.7

🔮 Strategic Highlights & Near-Term Outlook

✅ Expansion into Bengaluru’s Sarjapur market with a 700-bed integrated facility
✅ Strategic MoUs & innovations in telehealth, diagnostics, and digital pharmacy
✅ Occupancy trends improving across metros; ARPOB at ₹63,569/day

🔭 Outlook FY26–FY30

Apollo Hospitals is well-positioned to benefit from:

India’s rising healthcare demand
Institutional trust in its clinical excellence
Digital penetration via Apollo 24|7 and pharmacy chains

However, high valuations (PE ~76x) and aggressive CAPEX may weigh in the short term.

📢 Final Dividend Update

₹10/share Final Dividend (200%)
Total FY25 Dividend: ₹19/share (₹2,731.9 million payout)
Record Date: August 19, 2025 | Payout by: September 10, 2025

📌 Disclosure

This blog is prepared solely for educational and informational purposes and does not constitute investment advice or stock recommendation. Readers are advised to do their own research before making any financial decisions.